Institutional Biosafety Committee (IBC)

Dr. Jeanette Bennett, Psychological Science (Chair) (2026)
Dr. Way Sung, Bioinformatics and Genomics (Vice-Chair) (2025)
Dr. Jessica Schlueter, Bioinformatics and Genomics (2027)
Dr. Juan Vivero-Escoto, Chemistry (2025)
Dr. Valery Grdzelishvili, Biological Sciences (2027)
Dr. Amy Knab, external member (2027)
Dr. Cathy Moore, Biosafety Officer, ex-officio, voting

Dr. Olya Keen, Civil and Environmental Engineering (2025) alternate
Dr. Junya Tomida, Biological Sciences (2025) alternate
Dr. Boa-Hua Song, Biological Sciences (2025) alternate
Dr. Richard A. White III, Bioinformatics and Genomics (2025) alternate
Dr. Rafael F.C. Vieira, Public Health Sciences (2026) alternate
Dr. Sheetal Ghelani, external member (2025) alternate

Dr. Melissa Stair, Acting Attending Veterinarian, ex-officio, non-voting
Dr. Linda Robles, Environmental Health and Safety Office, ex-officio, non-voting

Mr. Brian Stewart, Environmental Health and Safety Office, ex-officio, non-voting, alternate

Terms expire July 31 of the listed year.

Institutional Review Entity (IRE)

A sub-committee of the IBC, along with expert advisors, established to review research proposals involving biological agents and toxins that may pose risks to public health, agriculture, food security, economic security, or national security. This review is conducted in accordance with the USG Policy for Oversight of Dual Use Research of Concern (DURC) and Pathogens with Enhanced Pandemic Potential (PEPP).